Investor's Business Daily on MSN
Amprius Technologies gets IBD stock rating upgrade
The IBD SmartSelect Composite Rating for Amprius Technologies increased from 94 to 96 Monday.
Investor's Business Daily on MSN
IBD stock of the day: Ligand Pharma, biotech's royalty arm, breaks out
Ligand Pharmaceuticals is Tuesday's IBD Stock Of The Day. The biotech stock has blown past several buy points on its way to a new breakout.
LOS ANGELES--(BUSINESS WIRE)--Investor’s Business Daily (IBD), a digital publishing business that provides authoritative stock market analysis, investing education and research tools, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results